Clinical Trial Update: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC [NA]

View source ↗

Summary

Clinical trial evaluating nystatin pastilles to prevent oral candidiasis in patients with AIDS or ARC has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Oral Candidiasis

Drugs mentioned

• Nystatin Pastilles (Nystatin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Candidiasis, Oral, HIV Infections | NA | Status: COMPLETED